Skip to main content

Table 1 The 29 genes identified in our previous genetic interaction study on bladder cancer using SEN

From: Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility

Symbol Entrez Gene ID Description
AHRR 57491 Aryl-hydrocarbon receptor repressor
AKR1C3 8644 Aldo-keto reductase family 1, member C3
AXIN2 8313 Axin2
BCL6 604 B-cell CLL/lymphoma 6
BIRC3 330 Baculoviral IAP repeat containing 3
CARD15 64127 Nucleotide-binding oligomerization domain containing 2
CAT 847 Catalase
CCL5 6352 Chemokine (C-C motif) ligand 5
CCNH 902 Cyclin H
FTHFD 10840 Aldehyde dehydrogenase 1 family, member L1
GATA3 2625 GATA binding protein 3
GSTM3 2947 Glutathione S-transferase mu 3 (brain)
HSD17B4 3295 Hydroxysteroid (17-beta) dehydrogenase 4
IGF1R 3480 Insulin-like growth factor 1 receptor
IL1A 3552 Interleukin 1, alpha
INSR 3643 Insulin receptor
MASP1 5648 Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
MBD2 8932 Methyl-CpG binding domain protein 2
MMP1 4312 Matrix metallopeptidase 1 (interstitial collagenase)
MYBL2 4605 V-myb myeloblastosis viral oncogene homolog (avian)-like 2
NEDD5 4735 Septin 2
OPRM1 4988 Opioid receptor, mu 1
PARP4 143 Poly (ADP-ribose) polymerase family, member 4
PGR 5241 Progesterone receptor
PIM1 5292 Pim-1 oncogene
RERG 85004 RAS-like, estrogen-regulated, growth inhibitor
TNKS 8658 Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
TP53I3 9540 Tumor protein p53 inducible protein 3
XPC 7508 Xeroderma pigmentosum, complementation group C